How ID NOW Tackles COVID | 合法醫療器材資訊網

IDNOWisoneofthemostwidely-availablemolecularpoint-of-caretestingtechnologiesinuseintheU.S.Sinceitsintroductionin2014,ithasbeenusedin​ ...

ID NOW is one of the most widely-available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians offices and urgent care centers to rapidly detect influenzas A & B, strep A, and respiratory syncytial virus (RSV). When faced with the threat of novel coronavirus, our scientists mobilized to quickly bring a new COVID-19 detection test to the fight against this deadly virus.

Because of its ease of use, portability and rapid results, ID NOW is providing frontline healthcare workers with a tool[1] that they hoped for when the COVID-19 pandemic first took hold across the world. Rapid tests are part of the equation along with high-volume lab-based tests to identify patients with active infections. ID NOW is an FDA approved CLIA-waived[2] instrument, which means that the technology can be used in settings outside the tradi...